Pulse Contour Analysis for Prediction of Fluid Responsiveness in Preeclamptic Patients: A Case Series Volume 5 - Issue 3

Luciano Frassanito*¹, Massimo Antonelli1¹,Antonio Messina² ,Davide Colombosa²and Gaetano Draisci¹

• ¹ Area Anestesiologia, Rianimazione, Terapie Intensive e Terapia del Dolore, Rome, Italy
• ² Department of Emergency Medicine, Ospedale Maggiore della Carità, Novara, Italy

Received: June 01, 2018;   Published: June 12, 2018

*Corresponding author: Luciano Frassanito, Istituto di Anestesia e Rianimazione, Policlinico A. Gemelli Foundation, largo A. Gemelli 8, 00168 Rome, Italy

DOI: 10.26717/BJSTR.2018.05.001210

Abstract PDF

Preeclampsia (PE) is a pregnancy-specific syndrome characterized by maternal cardiac output (CO) alterations and relative hypovolemia. In patients with PE is mandatory to predict Fluid Responsiveness (FR), above all if caesarean section (CS) under spinal anesthesia is required. The fluid challenge (FC) is a diagnostic approach to hemodynamic management which aims at identifying the patients who respond to fluid administration with an increase in CO. We present a case series to evaluate the effectiveness of a FC in increasing Cardiac Index (CI) in a group of preeclamptic patients using a continuous pulse-contour analysis. We studied the percentage of patients with PE scheduled for caesarean delivery who had a 15% increase of CI after a FC, in comparison with a control group of healthy pregnant patients. At baseline the patients in PE group showed higher Mean Arterial Pressure (MAP) and lower Stroke Volume Index (SVI). Fifteen patients were non responders (69% of the patients in PE group and 46% of the patients in control). We suggest that the hemodynamic measurement of CI is useful to guide fluid therapy in pregnant woman with PE, and caution should be taken during fluid administration in all healthy pregnant woman at term.

Abbreviations: PE: Preeclampsia, CO: Cardiac Output, CS: Caesarean Section, FC: Fluid Challenge, CI: Cardiac Index, MAP: Mean Arterial Pressure, SVI: Stroke Volume Index, FR: Fluid Responsiveness, SV: Stroke Volume

Preeclampsia (PE) is a pregnancy-specific multi-organ syndrome secondary to generalized vascular endothelial activation and vasospasm [1,2]. Maternal hemodynamic state is characterized by high vascular resistances, cardiac output (CO) alterations and relative hypovolemia [2]. Above all the women who develop “early onset” PE (time of the diagnosis at or before 34 weeks of gestational age) show evidence of left ventricular mild diastolic dysfunction and segmental impaired myocardial relaxation [2]. Several authors stated that assessment of maternal hemodynamic in women with PE is fundamental for appropriate fluid management [3,4]. Insufficient intravascular volume as fluid excess can lead to life-threatening scenarios, such as decreased oxygen delivery to tissues with multiorgan dysfunction, or fluid extravasation and pulmonary oedema [4]. Poor fluid management in PE has been reported as leading cause of admission to an intensive care unit and maternal deaths [3].

In these patients is mandatory to predict fluid responsiveness (FR), especially if caesarean section under spinal anesthesia is required, as adequate fluid therapy aimed at optimization of CO could be effective to prevent spinal induced hypotension and uteroplacental hypoperfusion [5]. Different studies suggested some strategies to evaluate fluid responsiveness [3,6]. but the debate about the best way to assess it is still open. The fluid challenge (FC) is a reliable diagnostic approach to hemodynamic management which aims at identifying the patients who respond to fluid administration with an increase in blood pressure or CO [7,8]. To our knowledge, FC with CO analysis was never tested in PE. We, therefore decided to evaluate if a FC might have the ability to predict FR in a group of preeclamptic patients using a continuous pulse-contour analysis.

Patients

After internal Medical Ethics Committee approval and collection of informed consent to analysis and publication of data from the women enrolled, we studied the percentage of patients with early-onset PE scheduled for caesarean delivery (13 patients, PE Group) who had a 15% increase of Cardiac Index (CI) after a FC, in comparison with a control group of healthy pregnant patients (13 patients, CC Group) undergoing caesarean section for placenta previa. Non-invasive hemodynamic monitoring was performed in all patients as internal clinical practice in our centre. In PE gro all the patients were treated with Metildopa 500 mg 3 times daily, plus Nifedipine 30 mg twice a day for 2 cases. LiDCO plus monitor (LiDCO Ltd., Cambridge, UK) was used to calculate stroke volume (SV) from arterial waveform by autocorrelation algorithm [9].

Two consecutive calibrations with lithium chloride were used to convert nominal to actual SV and CO. We gave an arbitrary value of central venous pressure of 5 mmHg. We considered as baseline values the registration of one minute recorded three minutes after calibration of the monitor. The test of fluid responsiveness was carried out with Ringer Lactate solution 500 ml infused within 5 min. Data were elaborated with LiDCOviewTM program. The analysis of modification of hemodynamic variables minute to minute during FC was performed. Differences between the absolute value of variables within each group were studied, and baseline was chosen as control variable. For each hemodynamic variable the differences between PE and CC were evaluated by means of Unpaired t-test or Mann- Whitney test when appropriate. The percentage of increase in CI, the difference between PE and CC and rate of early complication in both groups were evaluated.

At baseline the patients in PE group showed higher mean arterial pressure and lower Stroke Volume Index, as compared to CC as showed in (Table1), but only the difference in MAP reached statistical significance. Overall 15 patients were not able to respond to FC with an increase in CI (non-responders, NR): 9 patients (69%) were in PE group, while 6 (46%) in CC group. Among responders the mean C.I. average (ΔCI) was 1.1 + 1.5 L/min/m2, SVI mean raise was 6.4 + 8.8 ml/m2/beat. No significant changes in HR, MAP and SVRI was recorded (Figure 1) shows the distribution of fluid responsiveness in the two groups: ΔCI after FC was significantly lower in women with severe PE (p=0.002).

Figure 1: Box-and-whisker plot of Delta C.I., variation of cardiac index induced by fluid challenge (L/min/m2), in 13 women with severe preeclampsia (PE group) and in 13 healthy controls. Delta C.I. was higher in CC group than in PE group (p = 0.002). *p<0.05. Boxes with internal lines represent median and interquartile range and whiskers are range.

Table 1: Hemodynamic data of the two group of patients at baseline. The patients in PE group showed higher mean arterial pressure (* = p<0.05).

In normal pregnancy vascular dilation, reduction in arterial pressure and increased heart rate cause an increased CO. In PE, both a “hyperdynamic” state with high CO and low vascular resistance and a “hypodynamic” state with high resistances, low CO and low plasma volume are described [1,2]. Particularly the so called “earlyonset” PE (before 34 weeks of gestation) is characterized by high vascular resistance and low CO, whereas “late onset” preeclampsia is dominated by high CO and low vascular resistance [1,2]. In early-onset preeclampsia, the endothelial dysfunction produces the haemodynamic changes, organ dysfunction and foetal growth restriction [1]. Several authors studied haemodynamic in PE using noninvasive monitoring tools, demonstrating these findings [2]. At our knowledge this is the first study to evaluate the ability of a FC to increase CO in spontaneously breathing patients affected by severe PE by a beat-to-beat analysis of SV. Our findings are in accordance with previous data [2,3,10]. Brun et al studied a population of 44 patients affected by severe PE and reported that only 52% of the patients who developed oliguria responded to a fluid challenge [3]. The authors outlined the poor predictive value of clinical features such as oliguria to assess fluid responsiveness and guide fluid management [3].

Ambrozic et al showed that severe PE is associated with ultrasound evidence of increase in extravascular lung water and disturbed diastolic left ventricular function compared with healthy pregnancies, and they found only a small proportion (about 14%) of women with severe PE to be fluid responsive to passive leg raising [10]. Moreover, they observed a small percentage (67%) of fluid responders to passive leg raising also among control group of healthy pregnant women at term. Nevertheless the compression of inferior vena cava by the gravid uterus in pregnant women at term, and the increased abdominal pressure make questionable the validity of passive leg raising in these clinical scenario, despite some authors argued in favor of it [3,11]. In our opinion is remarkable the finding that about one in two patients among healthy pregnant resulted NR to FC. A reduction in diastolic performance could be the main reason of these findings. Indeed Melchiorre et al. showed a tendency toward reduced diastolic reserve and impaired chamber diastolic function in a large population of pregnant women at term subjected to echocardiography [12]. A mild degree of diastolic dysfunction and segmental myocardial diastolic dysfunction were seen respectively in 17,9% and 28,4% of the women [12]. FC seems to be a reliable test that not requires specific expertise as compared to echocardiographic assessment. Moreover, it does not add invasively manoeuvre to PE normal management, but it allows a continuous monitoring that potentially might be useful to address and evaluate different therapeutic strategies according to fluid responsiveness. Further studies are required to evaluate the benefit of this monitoring in guide clinical decision. In conclusion we suggest that the hemodynamic measurement of CO and SV may be useful to guide fluid therapy in pregnant woman with SPE; moreover, caution should be taken during fluid administration in healthy pregnant woman at term undergoing to surgery.

Assistance with the study: We would like to thank Professor R. Proietti for his assistance with the study.

Financial support and sponsorship: This work was supported by the Department of Anaesthesiology and Intensive Care, Policlinico A. Gemelli Foundation, Rome.

1. Wortmann SB, Mayr JA, Nuoffer JM, Prokisch H, Sperl W (2017) A Guideline for the Diagnosis of Pediatric Mitochondrial Disease: The Value of Muscle and Skin Biopsies in the Genetics Era. Neuropediatrics 48(4): 309-314.
2. Skladal D, Sudmeier C, Konstantopoulou V, Stöckler-Ipsiroglu S, Plecko- Startinig B, et al. (2003) The clinical spectrum of mitochondrial disease in 75 pediatric patients. Clin Pediatr. (Phila) 42(8): 703-710.
3. Kremer LS, Bader DM, Mertes C, Kopajtich R, Pichler G, et al. (2017) Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun 12: 15824.
4. Verdijk RM, de Krijger R, Schoonderwoerd K, Tiranti V, Smeets H, et al. (2008) Phenotypic consequences of a novel SCO2 gene mutation. Am J Med Genet A 146A(21): 2822-2827.
5. Pronicki M, Kowalski P, Piekutowska-Abramczuk D, Taybert J, Karkucinska- Wieckowska A, et al. (2010) A homozygous mutation in the SCO2 gene causes a spinal muscular atrophy like presentation with stridor and respiratory insufficiency. Eur J Paediatr Neurol 14(3): 253- 260.
6. Dickinson EK, Adams DL, Schon EA, Glerum DM (2000) A human SCO2 mutation helps define the role of Sco1p in the cytochrome oxidase assembly pathway. J Biol Chem 275(35): 26780-26785.
7. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, et al. (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23(3): 333-337.
8. Gurgel-Giannetti J, Oliveira G, Brasileiro Filho G, Martins P, Vainzof M, et al. (2013) Mitochondrial cardioencephalomyopathy due to a novel SCO2 mutation in a Brazilian patient: case report and literature review. JAMA Neurol 70(2): 258-261.
9. Leary SC, Cobine PA, Kaufman BA, Guercin GH, Mattman A, et al. (2007) The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis. Cell Metab 5(1): 9-20.
10. Jaksch M, Ogilvie I, Yao J, Kortenhaus G, Bresser HG, et al. (2000) Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. Hum Mol Genet. 9(5):795-801.
11. Vesela K, Hansikova H, Tesarova M, Martasek P, Elleder M, et al. (2004) Clinical, biochemical and molecular analyses of six patients with isolated cytochrome c oxidase deficiency due to mutations in the SCO2 gene. Acta Paediatr 93(10): 1312-1317.
12. Salviati L, Sacconi S, Rasalan MM, Kronn DF, Braun A, et al. (2002) Cytochrome c oxidase deficiency due to a novel SCO2 mutation mimics Werdnig-Hoffmann disease. Arch Neurol 59(5): 862-865.
13. Freisinger P, Horvath R, Macmillan C, Peters J, Jaksch M (2004) Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper? J Inherit Metab Dis 27(1): 67- 79.
14. Böhm M, Pronicka E, Karczmarewicz E, Pronicki M, Piekutowska- Abramczuk D, et al. (2006) Retrospective, multicentric study of 180 children with cytochrome C oxidase deficiency. Pediatr Res 59(1): 21-26.
15. Honzik T, Tesarova M, Magner M, Mayr J, Jesina P, et al. (2012) Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis. J Inherit Metab Dis 35(5): 749-759.